59088-795 NDC - FOLCYTEINE (MULTIVITAMIN)

Drug Information

Product NDC: 59088-795

Proprietary Name: Folcyteine

Non Proprietary Name: Multivitamin

Active Ingredient(s):
  • 200 mg/1 ACETYLCYSTEINE;
  • 47 mg/1 CALCIUM CITRATE;
  • 800 [iU]/1 CHOLECALCIFEROL;
  • 1000 ug/1 FOLIC ACID;
  • 16 mg/1 MAGNESIUM CITRATE


Administration Route(s): ORAL

Dosage Form(s): TABLET

Pharmacy Class(es):
  • Antidote [EPC];
  • Antidote for Acetaminophen Overdose [EPC];
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Calculi Dissolution Agent [EPC];
  • Cations;
  • Divalent [CS];
  • Decreased Respiratory Secretion Viscosity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Glutathione Concentration [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Mucolytic [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA];
  • Reduction Activity [MoA];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE];
  • Vitamin D [CS];
  • Vitamin D [EPC]

Labeler Information

Labeler Name: PureTek Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:9/14/2023

Package Information

No. Package Code Package Description Billing Unit
159088-795-5430 TABLET in 1 BOTTLE, PLASTIC (59088-795-54)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC59088-795The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFolcyteineThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEMultivitaminThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/14/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEPureTek CorporationName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACETYLCYSTEINE; CALCIUM CITRATE; CHOLECALCIFEROL; FOLIC ACID; MAGNESIUM CITRATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH200; 47; 800; 1000; 16 
ACTIVE INGRED UNITmg/1; mg/1; [iU]/1; ug/1; mg/1 
PHARM CLASSESAntidote [EPC], Antidote for Acetaminophen Overdose [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Decreased Respiratory Secretion Viscosity [PE], Increased Coagulation Factor Activity [PE], Increased Glutathione Concentration [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Mucolytic [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Reduction Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin D [CS], Vitamin D [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/12/2024